Yes, hydroxyzine is a first-generation H1 receptor antagonist (H1 blocker).
Hydroxyzine is definitively classified as a first-generation H1 antihistamine, alongside diphenhydramine and chlorpheniramine 1. This classification is consistently confirmed across multiple authoritative guidelines from the American Academy of Allergy, Asthma & Immunology (AAAAI) published in 2019 in the Journal of Allergy and Clinical Immunology.
Mechanism and Pharmacology
Hydroxyzine functions as an H1 receptor antagonist with additional pharmacologic properties 2:
- Primary action: Blocks histamine at H1 receptors
- Secondary effects: Anticholinergic activity, antiemetic properties, and bronchodilator activity
- Onset: Clinical effects typically noted within 15-30 minutes after oral administration
- CNS penetration: Unlike its metabolite cetirizine (a second-generation antihistamine), hydroxyzine readily crosses the blood-brain barrier 3
Critical Clinical Distinctions from Second-Generation Antihistamines
The key difference between hydroxyzine and newer antihistamines is its significant CNS penetration and associated adverse effects 4:
Sedation and Performance Impairment
- Causes drowsiness and performance impairment in many patients 4
- Drivers taking hydroxyzine are 1.5 times more likely to be responsible for fatal automobile accidents 4
- Impaired driving performance worsens with cellular phone use 4
- Performance impairment can exist without subjective awareness of drowsiness 4
Anticholinergic Effects
- Dry mouth and eyes
- Constipation
- Urinary retention
- Increased risk of narrow-angle glaucoma provocation 4
Cognitive Decline Risk
Particularly concerning in elderly populations, H1 blockers with anticholinergic effects like hydroxyzine are associated with cognitive decline 1. Elderly patients are more sensitive to psychomotor impairment and at increased risk for falls, fractures, and subdural hematomas 4.
Cardiac Concerns
- Cases of QT prolongation and Torsade de Pointes reported in post-marketing surveillance 2
- Should be used with caution in patients with cardiac risk factors, recent myocardial infarction, uncompensated heart failure, or bradyarrhythmias 2
- One case report documented syncope in a patient with HERG mutation taking hydroxyzine 5
Clinical Context and Guideline Recommendations
When Hydroxyzine May Be Used
Despite its first-generation classification, hydroxyzine has specific clinical applications 1:
- Mast cell activation syndrome (MCAS): Listed as a treatment option, though with noted limitations
- Sedation desired: When bedtime sedation is specifically needed
- Refractory cases: When second-generation antihistamines have failed
Important Caveats
Current evidence does NOT support the common practice of combining a second-generation antihistamine in the morning with hydroxyzine at night 6. A 2014 randomized controlled trial in chronic spontaneous urticaria found:
- Adding hydroxyzine 50 mg at night to levocetirizine provided no additional benefit over levocetirizine monotherapy
- Hydroxyzine increased daytime somnolence (p=0.026)
- Both treatments equally reduced urticaria symptoms and improved quality of life
First-generation antihistamines dosed only at bedtime still cause significant daytime drowsiness due to prolonged plasma half-lives and persistent end-organ effects 4.
Preferred Alternative: Second-Generation Antihistamines
Guidelines consistently recommend second-generation antihistamines (cetirizine, fexofenadine, loratadine) as first-line therapy 1:
- Less or no CNS penetration
- Minimal sedation
- No anticholinergic effects
- Can be safely increased to 2-4 times FDA-approved doses for refractory symptoms 1
Cetirizine Connection
Cetirizine is the carboxylated metabolite of hydroxyzine that retains antihistaminic activity but with dramatically reduced CNS effects due to relative exclusion from the CNS compartment 3. This makes cetirizine a safer alternative with similar efficacy.
Dosing Considerations
When hydroxyzine must be used 2:
- Elderly patients: Start at low doses and observe closely due to increased sensitivity
- Renal impairment: Halve the dose 7
- Hepatic impairment: Avoid in severe liver disease 7
- Pregnancy: Specifically contraindicated in early pregnancy 7
Bottom Line
Hydroxyzine is unequivocally a first-generation H1 blocker, but its use should be reserved for specific situations where second-generation antihistamines have failed or when sedation is specifically desired, with full awareness of its significant adverse effect profile, particularly regarding sedation, cognitive impairment in the elderly, and potential cardiac effects.